The development of metastases is a decisive step in the course of a cancer disease. The detection of metastases in cancer patients is correlated with a poor prognosis, and over 90% of all deaths from cancer are not due to the primary tumor, which often can be successfully treated, but are due to the metastases. Tumor cell migration, a prerequisite for metastasis development, is not merely genetically determined, but is distinctly regulated by signal substances of the environment including chemokines and neurotransmitters. We have shown previously that the migration of breast, prostate, and colon carcinoma cells is enhanced by the stress-related neurotransmitter norepinephrine in vitro, and that this effect can be inhibited by the b-blocker propranolol. We now provide for the first time evidence for the in vivo relevance of this neurotransmitter-driven regulation using PC-3 prostate carcinoma cells. The development of lumbar lymph node metastases in athymic BALB/c nude mice increased with the application of norepinephrine via microosmotic pumps, while propranolol inhibited this effect. However, the growth of the primary tumor was not affected by either treatment. Additionally, experiments using human tissue microarrays showed that 70-90 percent of breast, colon, and prostate carcinoma tissues express the relevant b2-adrenoceptor. Thus, our work contributes to the understanding of the basic cellular mechanisms of metastasis development, and furthermore delivers a rationale for the chemopreventive use of clinically established b-blockers for the inhibition of metastases. 1 Their theory is supported by the finding that certain mutations, e.g. mutations of the tumor-suppressor gene MADH4, occur more frequently in metastatic tumors.2 On the other hand, the comparative gene expression profiling of primary breast tumors and distant metastases showed striking similarity, suggesting that the metastatic capability in breast cancer is an inherent feature and is not based on clonal selection.3 Recent research has shown that ligands to serpentine receptors play an important role in the regulation of tumor cell migration. These ligands predominantly consist of 2 groups, the chemokines and the neurotransmitters. 4 Among the chemokines, the stromal cell-derived factor-1 (SDF-1) is best investigated for its role in metastasis development, 5 and in the localization of metastases as shown in mice.6 Within the group of neurotransmitters, norepinephrine is one of the most potent known stimulators for the migration of tumor cells. We have shown previously in this journal and elsewhere that norepinephrine induces migration in breast, colon and prostate carcinoma cells, and that this induction can be inhibited by b2-adrenoceptor blocking drugs in vitro. [7][8][9] In this present study, we address the question whether the previously observed increase of tumor cell migration in response to norepinephrine in vitro corresponds to an in vivo increase of metastasis development in mice, and whether this effect can be inhibited by the chemoprev...

No abstract

The active migration of tumor cells, a crucial requirement for metastasis development and cancer progression, is regulated by signal substances including neurotransmitters. We investigated the migration of tumor cells within a threedimensional collagen matrix using time-lapse videomicroscopy and computer-assisted analysis of the migration path. Tumor cell migration is induced by norepinephrine, dopamine and substance P. We show that this induced migration, using MDA-MB-468 breast and PC-3 prostate carcinoma cells, can be inhibited by using specific, clinically established receptor antagonists to the ␤2-adrenoceptor, the D2 receptor, or the neurokinin-1 receptor, respectively. All of the investigated neurotransmitters significantly activated the cyclic adenosine-monophosphate response element binding protein (CREB). Furthermore, microarray analysis revealed changes of gene expression toward a highly motile tumor cell type, including an upregulation of the ␣2 integrin, which is an essential adhesion receptor for collagen in migration. The gene for the tumor suppressor gelsolin was downregulated. These 2 critical alterations were confirmed on the protein level by flow-cytometry and immunoblotting, respectively. Neurotransmitters thus induce a metastatogenic tumor cell type by directly regulating gene expression and increased migratory activity, which can be prevented by established neurotransmitter antagonists. © 2004 Wiley-Liss, Inc. Key words: metastasis formation; tumor cell migration; neurotransmitters; signal transduction; gene expressionMost patients suffering from cancer do not die due to the primary tumor, but from distant metastases descending from it. The development of these metastases is a multi-step process for which the metastasizing tumor cells need to acquire the ability of active migration. This migratory activity is not solely an intrinsic property of tumor cells, but a cell function which is regulated by signal substances similar to the regulation of migratory activity in leukocytes. 1 Chemokines are the key regulatory signal substances of the immune system, whereas neurotransmitters are also known to regulate the adhesion, migration, and homing of leukocytes. 2 In addition to their function in the immune system, chemokines have been shown to induce the migration of tumor cells, 2,3 and direct the tumor cells to specific organs. 4 The involvement of psychosocial factors in the incidence and progression of cancer has also been discussed for decades and has been reviewed recently by Heffner et al. 5 In further support of this psycho neuro-oncological link we identified neurotransmitters, which induce the migration of MDA-MB-468 breast carcinoma cells. 6 Norepinephrine was the most potent inducer of migration. This induction of migration is not based on a recruitment of formerly non-migrating cells, but is a very subtle composition of changes of migratory parameters such as of the velocity as well as of the frequency and duration of pauses during migratory activity; morphological changes, e.g., with...

Purpose: After apparently successful excision of breast cancer, risk of local recurrence remains high mainly in the area surrounding the original tumor, indicating that wound healing processes may be implicated.The proportional reduction of this risk by radiotherapy does not depend on the extent of surgery, suggesting that radiotherapy, in addition to killing tumor cells, may influence the tumor microenvironment. Experimental Design: We studied how normaland mammary carcinoma cell growth and motility are affectedby surgical wound fluids (WF), collectedover 24 hfollowingbreast-conserving surgery in 45 patients, 20 of whomhadreceivedadditionalTARGeted Intraoperative radioTherapy (TARGIT), immediately after the surgical excision. The proteomic profile of the WF and their effects on the activation of intracellular signal transduction pathways of breast cancer cells were also analyzed. Results: WF stimulated proliferation, migration, and invasion of breast cancer cell lines.The stimulatory effect was almost completely abrogated when fluids from TARGIT-treated patients were used. These fluids displayed altered expression of several cytokines and failed to properly stimulate the activation of some intracellular signal transduction pathways, when compared with fluids harvested from untreated patients. Conclusions: Delivery of TARGIT to the tumor bed alters the molecular composition and biological activity of surgical WF. This novel antitumoral effect could, at least partially, explain the very low recurrence rates found in a large pilot study using TARGIT. It also opens a novel avenue for identifying new molecular targets and testing novel therapeutic agents.

Most patients suffering from breast carcinoma do not die due to the primary tumor but from the development of metastases. Active migration of cancer cells is a prerequisite for development of these metastases. We used time-lapse videomicroscopy and computer-assisted cell tracking of MDA-MB-468 human breast carcinoma cells, which were incorporated into a three-dimensional collagen matrix, in order to analyze the migratory activity of these cells in response to different neurotransmitters. Our results show that met-enkephalin, substance P, bombesin, dopamine, and norepinephrine have a stimulatory effect on the migration of the breast cancer cells; moreover, these cells show positive chemotaxis towards norepinephrine as was analyzed by the directionality and persistence on a single-cell basis. Gamma-aminobutyric acid (GABA) however has an inhibitory effect. Endorphin and leu-enkephalin, as well as histamin and acetylcholine, had no influence on the migratory activity of the cells. In summary, we provide evidence for a strong regulatory involvement of neurotransmitters in the regulation of breast cancer cell migration, which might provide the basis for the use of the pharmacological agonists and antagonists for the chemopreventive inhibition of metastasis development.